Programmable Infusion Pumps Market: Current Analysis and Forecast (2023-2030)
Emphasis on Type (Wearable, Mobile-Based Applications, Sensors, and Others); Therapeutic Area (Cardiovascular and Metabolic Disorders (CVMD), Respiratory Disorders, Psychiatric Disorders, Sleep & Movement Disease, Neurological Disorders, Musculoskeletal Disorders, and Others); End-Use (Healthcare Companies, Healthcare Providers, Payers, and Others); and Region/Country
The Programmable Infusion Pumps market held 500 million in 2022 and is expected to grow at a strong CAGR of around 8% during the forecast period (2023-2030). Programmable infusion pumps are designed to be highly accurate and reliable, with features that allow healthcare providers to customize treatment protocols to meet the individual needs of each patient. These devices typically include advanced software and algorithms that can automatically adjust the infusion rate based on factors such as the patient’s weight, age, and medical history. The Programmable Infusion Pumps market is a rapidly growing industry that involves the development and manufacturing of medical devices that can deliver precise and controlled amounts of medication to patients. The increasing prevalence of chronic diseases is the major factor responsible for the growth of programmable infusion pumps. For instance, as per WHO, Cardiovascular disease (CVD) is the leading cause of death worldwide, claiming the lives of approximately 17.9 million people each year.
Some of the major players operating in the market are ICU Medical, Inc; Smiths Group plc.; Baxter; Fresenius Medical Care; Johnson & Johnson Private Limited; Medtronic; BD; Terumo Corporation; B. Braun SE; and Moog Inc Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst modality, the portable segment is expected to grow at the highest CAGR during the forecast period.”
Based on modality, the market is segmented into portable and stationary. As per our analysis, the portable segment is expected to grow at the highest CAGR during the forecast period. Many patients with chronic conditions such as diabetes, cancer, and rheumatoid arthritis require regular infusions of medication to manage their condition. Portable infusion pumps allow these patients to receive treatment outside of a hospital or clinical setting, which can improve their quality of life and reduce the burden on healthcare providers.
“Amongst application, the diabetes segment held the dominant share in 2022.”
Based on the application, the market is segmented into oncology, pediatrics, pain, diabetes, and others. As per our analysis, the diabetes segment held the dominant share in 2022. The Diabetes Programmable Infusion Pumps market is growing rapidly, driven by factors such as the increasing prevalence of diabetes, the aging of the population, and the growing demand for advanced medical technologies. According to the World Health Organization, there are currently over 460 million people worldwide with diabetes, and this number is expected to continue to rise in the coming years.
Amongst end-user, the homecare settings segment is expected to grow at the highest CAGR during the forecast period.”
Based on end-user, the market is segmented into hospitals, ambulatory surgical centers, homecare settings, and others. As per our analysis, the homecare settings segment is expected to grow at the highest CAGR during the forecast period. The increasing technological advancements and the launch of less complex devices are the major attributing factors for the growth of the homecare settings segment.
“Asia Pacific is expected to grow with the highest CAGR Programmable Infusion Pumps market during the forecast period.”
The Asia Pacific programmable infusion pumps market is growing rapidly, driven by factors such as the increasing prevalence of chronic diseases, the aging of the population, and the growing demand for healthcare services in the region. With advances in technology, programmable infusion pumps have become more user-friendly and easier to use, making them a more attractive option for patients and healthcare providers in the Asia Pacific region.
Programmable Infusion Pumps Market Report Coverage
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global programmable infusion pumps market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Programmable Infusion Pumps Market Analysis (2022-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Programmable Infusion Pumps market were the three major steps undertaken to create and analyze the adoption of Programmable Infusion Pumps in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of global Programmable Infusion Pumps market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Programmable Infusion Pumps market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Programmable Infusion Pumps market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type, therapeutic area, and end-use. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Programmable Infusion Pumps market. Further, we conducted factor analysis using dependent and independent variables such as type, therapeutic area, and end-use of the Programmable Infusion Pumps market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Programmable Infusion Pumps market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Programmable Infusion Pumps market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the Programmable Infusion Pumps market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global Programmable Infusion Pumps market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Programmable Infusion Pumps market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the type, therapeutic area, and end-use in the global Programmable Infusion Pumps market.
The main objective of the Global Programmable Infusion Pumps Market Study
The current & future market trends of the global Programmable Infusion Pumps market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the Programmable Infusion Pumps market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of type, therapeutic area, and end-use.
- Define and analysis of the regulatory framework for the Programmable Infusion Pumps industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the Programmable Infusion Pumps market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the Programmable Infusion Pumps market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
